Vaccines, blood, antisera, toxins and cultures in   Denmark

Exports In 2023, Denmark exported $3.78B in Vaccines, blood, antisera, toxins and cultures, making it the 16th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 2nd most exported product in Denmark. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Denmark are: Netherlands ($1.01B), United States ($789M), Switzerland ($378M), Germany ($214M), and Italy ($154M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Denmark between 2022 and 2023 were Netherlands ($885M), United States ($361M), and Switzerland ($272M).

Imports In 2023, Denmark imported $1.36B in Vaccines, blood, antisera, toxins and cultures, becoming the 28th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 11th most imported product in Denmark. Denmark imports Vaccines, blood, antisera, toxins and cultures primarily from: Germany ($409M), Belgium ($197M), United States ($158M), Netherlands ($128M), and Switzerland ($87.1M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Denmark between 2022 and 2023 were United States ($45.4M), Poland ($38.2M), and Switzerland ($19M).